| Study to Evaluate the Safety and Efficacy of ASC42 Tablets in Subjects With Primary Biliary Cholangitis (NCT05190523) | Gannex Pharma Co., Ltd. | 2022-04-06 |
| Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis (NCT05133336) | Zydus Therapeutics Inc. | 2022-04-01 |
| A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients (NCT05293938) | Intercept Pharmaceuticals | 2022-03-28 |
| A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness (NCT05014672) | Calliditas Therapeutics Suisse SA | 2022-02-14 |
| Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis (NCT05104853) | COUR Pharmaceutical Development Company, Inc. | 2022-01-25 |
| Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis (NCT05450887) | Nanjing Chia-tai Tianqing Pharmaceutical | 2021-09-23 |
| A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis (NCT05050136) | Mirum Pharmaceuticals, Inc. | 2021-09-22 |
| Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis (NCT04604652) | HighTide Biopharma Pty Ltd | 2021-05-27 |
| The Effectiveness of Combining Ursodeoxycholic Acid With Vitamin D in Treating Patients With Primary Biliary Cholangitis (NCT06309589) | Yilihamu·Abilitifu | 2021-05-01 |
| Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1 (NCT04618575) | West China Hospital | 2021-03-17 |
| Combination Antiretroviral Therapy (cART) for PBC (NCT03954327) | University of Alberta | 2021-03-01 |
| Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II (NCT04617561) | West China Hospital | 2020-11-01 |
| Clinical Research of Tapering UDCA in PBC Patients With a Complete Response (NCT04650243) | Peking Union Medical College Hospital | 2020-01-21 |
| Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC (NCT04594694) | Intercept Pharmaceuticals | 2019-10-02 |
| Prospective, Multicenter Cohort Study on Primary Biliary Cholangitis (NCT04076527) | University of Leipzig | 2019-09-19 |
| National Database on Primary Biliary Cholangitis (NCT05151809) | University of Milano Bicocca | 2019-09-19 |
| EXerCise Intervention in cholesTatic LivEr Disease: The EXCITED Study (NCT04265235) | University of Birmingham | 2019-04-07 |
| A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA (NCT03742973) | Eli Lilly and Company | 2019-03-28 |
| Mindfulness - Based Intervention in the Treatment of Fatigue in Patients With Primary Biliary Cholangitis (NCT03684187) | Yale University | 2018-11-19 |
| ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) (NCT03602560) | Gilead Sciences | 2018-10-01 |
| A Post-Authorisation Non-Interventional Observational of Patients in France With Primary Biliary Cholangitis Treated With Obeticholic Acid in Real Life (NCT03703076) | SAMEY | 2018-04-10 |
| A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis (NCT03345589) | West China Hospital | 2018-01-30 |
| Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Participants With Primary Biliary Cholangitis (NCT03155932) | Arena Pharmaceuticals | 2017-12-29 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (NCT03394924) | Enanta Pharmaceuticals, Inc | 2017-12-27 |
| Early Identification of Myocardial Impairment in PBC (NCT03545672) | RenJi Hospital | 2017-10-23 |
| Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid (NCT03092765) | EA Pharma Co., Ltd. | 2017-05-29 |
| Fenofibrate in Patients With Primary Biliary Cholangitis (PBC) (NCT06365424) | Xijing Hospital of Digestive Diseases | 2017-04-08 |
| Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis (NCT02943447) | Gilead Sciences | 2016-12-01 |
| The Effect of Bezafibrate on Cholestatic Itch (NCT02701166) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2016-02-01 |
| The Comparison About the Response of Ursodeoxycholic Acid in Primary Biliary Cholangitis Only and Primary Biliary Cholangitis With High Immune Globulin G or Aminotransferase at West China Hospital (NCT03322943) | West China Hospital | 2016-01-01 |
| A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients (NCT02516605) | Novartis Pharmaceuticals | 2015-09-09 |
| Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients (NCT05292872) | Intercept Pharmaceuticals | 2015-06-01 |